Intravenous fosphenytoin therapy for rescue of acute trigeminal neuralgia crisis in patients awaiting neurosurgical procedures: A cross-sectional study

•Few treatments exist for acute attacks of trigeminal neuralgia.•Patients who received intravenous fosphenytoin therapy were reviewed retrospectively.•Reduction in pain 24 h following treatment was significant with no adverse effects.•Intravenous fosphenytoin may be used to treat acute trigeminal ne...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical neuroscience 2021-12, Vol.94, p.59-64
Main Authors: Noro, Shusaku, Seo, Yoshinobu, Honjo, Kaori, Okuma, Masahiro, Asayama, Bunsho, Amano, Yuki, Kyono, Masanori, Sako, Kazuya, Nakamura, Hirohiko
Format: Article
Language:English
Subjects:
Acute pain
Fosphenytoin
Microvascular decompression surgery
Trigeminal neuralgia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Few treatments exist for acute attacks of trigeminal neuralgia.•Patients who received intravenous fosphenytoin therapy were reviewed retrospectively.•Reduction in pain 24 h following treatment was significant with no adverse effects.•Intravenous fosphenytoin may be used to treat acute trigeminal neuralgia crisis. Few treatments exist for acute attacks of trigeminal neuralgia. Therefore, this study aimed to investigate the efficacy and safety of an intravenous fosphenytoin therapy protocol in a trigeminal neuralgia crisis. We conducted a single-center, retrospective, observational study of the records of 20 patients with trigeminal neuralgia who received intravenous fosphenytoin therapy (15 mg/mL in normal saline at 50 mg/min for 15 min, total 750 mg) during hospitalization between September 2015 and August 2020. Serum phenytoin concentration was measured 30 min post-infusion. Pain severity was evaluated using a numerical rating scale and was analyzed for statistical significance. The mean age of the patients was 67.5 years (female, 50.0%). The median numerical rating scale score (interquartile range) of pain severity was 2.35 (0–10), 0.65 (0–5), 0.15 (0–1), 2.00 (0–8), and 4.30 (0–10) at 15, 30, and 60 min, and 12 and 24 h, respectively (p 
ISSN:0967-5868
1532-2653
DOI:10.1016/j.jocn.2021.09.040